Invasive approaches in the diagnosis of ILDs

C. Ravaglia (Forlì, Italy)

Source: Virtual Congress 2020 – Interstitial lung diseases
Session: Interstitial lung diseases
Session type: State of the art session
Number: 5060
Disease area: Interstitial lung diseases

WebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
C. Ravaglia (Forlì, Italy). Invasive approaches in the diagnosis of ILDs. Virtual Congress 2020 – Interstitial lung diseases

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Imaging techniques in the diagnosis of pleural diseases
Source: ISSN=1025-448x, ISBN=1-904097-25-1, page=76
Year: 2002

Invasive diagnostic procedures in nonhospital-acquired pneumonia: evaluation
Source: Eur Respir J 2001; 18: Suppl. 33, 463s
Year: 2001

Contribution of invasive methods in the diagnosis of pulmonary tuberculosis
Source: International Congress 2019 – Tuberculosis: diagnosis
Year: 2019

Invasive approaches to the aetiologic diagnosis: when and why?
Source: Annual Congress 2008 - Is microbiological diagnosis of community-acquired pneumonia possible and useful?
Year: 2008


Invasive respiratory aspergillosis is a treatable disease with early diagnosis and aggressive therapy
Source: Eur Respir J 2006; 28: Suppl. 50, 310s
Year: 2006

Invasive vs non-invasive techniques for diagnosing ventilatory acquired pneumonia
Source: Annual Congress 2010 - Healthcare-associated pneumonia: ventilator-associated pneumonia and pneumonia in hospitalised patients
Year: 2010


Diagnosis of interstitial lung diseases using eNose technology
Source: Virtual Congress 2020 – Promising biomarkers for idiopathic interstitial pneumonia
Year: 2020




Clinical diagnosis, monitoring and biomarkers in ILDs
Source: ERS Course 2016
Year: 2016




Clinical diagnosis, monitoring and biomarkers in ILDs
Source: ERS Course 2019 - Interstitial Lung Diseases
Year: 2019


Clinical diagnosis, monitoring and biomarkers in ILDs
Source: ERS Courses: Interstitial Lung Diseases
Year: 2019


Clinical diagnosis, monitoring and biomarkers in ILDs
Source: ERS Course 2019 - Interstitial Lung Diseases
Year: 2018

Invasive staging
Source: European Multidisciplinary Conference in Thoracic Oncology 2009
Year: 2009

Non invasive biomarkers in the diagnostic and prognostic evaluation of Pulmonary Fibrosis
Source: Research Seminar 2010 - Novel insights in pulmonary fibrogenesis: from bench to bedside Research Seminar
Year: 2010


Late Breaking Abstract - Sputum galactomannan and lateral-flow device tests for the diagnosis of invasive pulmonary aspergillosis in patients with underlying respiratory diseases
Source: International Congress 2019 – Pneumonia in 2019: antimicrobial resistance, cardiovascular complications and diagnosis
Year: 2019



Pulmonary aspergillosis – diagnostic and therapeutic challenges
Source: Eur Respir J 2005; 26: Suppl. 49, 170s
Year: 2005

Aetiology of CAP and HAP - role of noninvasive and invasive diagnostic methods
Source: Annual Congress 2003 - PG11 - Pneumonia epidemiology and diagnosis
Year: 2003

Thoracoscopy for diagnosis of interstitial pneumonias
Source: Eur Respir J 2002; 20: Suppl. 38, 71s
Year: 2002

The role of EBUS-TBNA in the diagnostic approach and staging of extrapulmonary tumors
Source: International Congress 2014 – New trends in bronchoscopy: EBUS-TBNA and endoscopic treatment of emphysema
Year: 2014